NeuroMetrix, Inc. (NURO) financial statements (2021 and earlier)
Company profile
| Business Address |
1000 WINTER STREET WALTHAM, MA 02451 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 3 | 7 | 4 | 4 | 12 | 9 | 9 | ||
| Cash and cash equivalents | 3 | 7 | 4 | 4 | 12 | 9 | 9 | ||
| Receivables | 0 | 1 | 1 | 1 | 1 | 1 | 0 | ||
| Inventory, net of allowances, customer advances and progress billings | 1 | 3 | 1 | 1 | 1 | 1 | 1 | ||
| Inventory | 1 | 3 | 1 | 1 | 1 | 1 | 1 | ||
| Deferred costs | 2 | 1 | |||||||
| Other undisclosed current assets | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||
| Total current assets: | 5 | 12 | 9 | 8 | 15 | 11 | 11 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 0 | 0 | 0 | 1 | 1 | 0 | 0 | ||
| Other undisclosed noncurrent assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Total noncurrent assets: | 1 | 0 | 0 | 1 | 1 | 0 | 0 | ||
| TOTAL ASSETS: | 7 | 12 | 10 | 8 | 16 | 11 | 11 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2 | 3 | 4 | 3 | 3 | 3 | 2 | ||
| Accounts payable | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||
| Accrued liabilities | 1 | 2 | 2 | 2 | 1 | 1 | 1 | ||
| Employee-related liabilities | 1 | 0 | 1 | 1 | 0 | ||||
| Taxes payable | 0 | 0 | |||||||
| Debt | 1 | ||||||||
| Deferred revenue and credits | ✕ | ✕ | 0 | 0 | 0 | ||||
| Other undisclosed current liabilities | 1 | 3 | 1 | 1 | (0) | (0) | |||
| Total current liabilities: | 3 | 6 | 5 | 3 | 3 | 3 | 2 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1 | ||||||||
| Operating lease, liability | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 0 | 0 | |||||||
| Deferred revenue and credits | ✕ | ✕ | 0 | 0 | |||||
| Other undisclosed noncurrent liabilities | 0 | 0 | 5 | 2 | |||||
| Total noncurrent liabilities: | 1 | 0 | 0 | 5 | 2 | ||||
| Total liabilities: | 4 | 6 | 5 | 3 | 3 | 8 | 4 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 3 | 6 | 5 | 5 | 13 | 3 | 7 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 197 | 197 | 196 | 183 | 176 | 158 | 154 | ||
| Accumulated deficit | (195) | (191) | (191) | (178) | (164) | (154) | (147) | ||
| Other undisclosed stockholders' equity attributable to parent | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Total stockholders' equity: | 3 | 6 | 5 | 5 | 13 | 3 | 7 | ||
| TOTAL LIABILITIES AND EQUITY: | 7 | 12 | 10 | 8 | 16 | 11 | 11 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 9 | 16 | 17 | 12 | 7 | 6 | 5 | |
| Other operating income | 12 | |||||||
| Cost of revenue | (7) | (9) | (10) | (7) | (4) | (3) | (2) | |
| Cost of goods and services sold | (3) | (0) | ||||||
| Gross profit: | 2 | 7 | 7 | 5 | 3 | 3 | 3 | |
| Operating expenses | (14) | (20) | (20) | (20) | (17) | (12) | (10) | |
| Operating loss: | (12) | (12) | (13) | (15) | (13) | (9) | (7) | |
| Nonoperating income (expense) | 8 | (0) | (0) | |||||
| Other nonoperating income (expense) | 8 | (0) | (0) | |||||
| Loss before gain (loss) on sale of properties: | (4) | (12) | (13) | (15) | (13) | (9) | (8) | |
| Other undisclosed net income | 12 | |||||||
| Net income (loss): | (4) | 0 | (13) | (15) | (13) | (9) | (8) | |
| Other undisclosed net income (loss) attributable to parent | 0 | 0 | 4 | 1 | (0) | |||
| Net income (loss) attributable to parent: | (4) | 0 | (13) | (15) | (9) | (8) | (8) | |
| Preferred stock dividends and other adjustments | (7) | (20) | ||||||
| Other undisclosed net loss available to common stockholders, basic | (12) | (3) | (1) | |||||
| Net income (loss) available to common stockholders, diluted: | (4) | 0 | (20) | (35) | (21) | (11) | (9) | |
Comprehensive Income ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (4) | 0 | (13) | (15) | (13) | (9) | (8) | |
| Comprehensive income (loss), net of tax, attributable to parent: | (4) | 0 | (13) | (15) | (13) | (9) | (8) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.